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TRANSLATIONAL IMMUNOLOGY IN KIDNEY DISEASE, ISN NEXUS SYMPOSIUM 2016correlated with the reduction of tubular injury (PAS, Kim-1), renal
inﬂammation (Macrophages, T cells, IL-6, TNF-, RANTES and
CCL2) as well as renal ﬁbrosis (SMA, Col1a1, Masson Trichrome).
Conclusions: Therefore, we conclude that BHB ameliorates acute
oxalate nephropathy, as well as delays progressive renal failure by
inhibiting NLRP3-mediated inﬂammation. Our ﬁndings suggest
that ketogenic diets or -hydroxybutyrate formulations can be used
therapeutically for the treatment of primary hyperoxaluria related
kidney stone disease.
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Introduction: A newly-described 1st-line immune defence mecha-
nisms of neutrophils is the extrusion of DNA, called neutrophil
extracellular traps (NETs). Known non-infectious triggers of
NETosis are phorbol 12-myristate 13-acetate (PMA), IL-8 and im-
mune complexes (ICx). In vitro, PMA and IL-8 are strong inducers
of NET release and generally involves all cultured neutrophils.
However, ICx induce much lower numbers of neutrophils to release
NETs. As such, the in vitro quantiﬁcation of NETs is challenging
with current methodologies (i.e. Picogreen or immunoﬂuorescence).
In order to investigate the role of NET release in ICx-mediated
autoimmune diseases, we developed a novel method for automated
and highly sensitive measurement of NETs, applicable in a
high-throughput system.
Methods: Healthy neutrophils are isolated from fresh blood and
labelled with the membrane staining PKH26, which serves as a cell
marker. Neutrophils are stimulated for 4 hours with various con-
centrations of heat-aggregated human IgG ICx. After 33/4 hours,
Sytox green is added to stain extracellular DNA. Sytox green is
incubated for 15 minutes, after which the cells are ﬁxed with 4%
PFA. Within 24 hours, the 96-well plate is automatically imaged
with the BD Pathway 855. The ratio of the sum of Sytox green area
and average PKH area is calculated, representing the amount of
NETs in each sample. A higher ratio indicates a higher amount of
extracellular DNA present.
Results: Immunoﬂuorescence analysis of ICx-stimulated neutro-
phils revealed colocalization of extracellular DNA staining with
citrullinated histon3 and neutrophil elastase, conﬁrming the release
of NETs. The amount of NET release was quantiﬁed with ImageJ
software, by determining the ratio between positive Sytox green
area and the positive PKH26 area, of which we found that it
accurately represents the amount of cells imaged. Sensitivity is
highly increased since 11% of the total area per well is imaged and
a z-stacking system is used to image NETs superimposed on neu-
trophils. We further characterized NET release upon stimulation
with these ICx. When pre-treated with diphenyleneiodonium (DPI),
used to block production of reactive oxygen species (ROS), NET
release upon ICx stimulation was not affected.Kidney International Reports (2016) 1, S1–S22Conclusions:We developed a novel assay that is highly sensitive to
detect and quantify in vitro NET release. NET release triggered by
human ICx was detected reliably and appeared to be a ROS-inde-
pendent process. This assay will allow high-throughput and highly
sensitive analysis of NET release in ICx-mediated autoimmune
diseases (e.g. systemic lupus erythematosus, rheumafactor positive
rheumatoid arthritis or cryoglobulinemic vasculitis).
P23
IL-33 ELICITS INNATE LYMPHOID
CELLS AND ALTERNATIVELY
ACTIVATED MACROPHAGES THAT
REDUCE RENAL ISCHEMIC-
REPERFUSION INJURY
Cao, Q1
1Westmead Millennium Institute for Medical Research, Centre for Trans-
plant and Renal Research, Westmead, Australia
Introduction: IL-33 is an important immune regulator which can
promote Th2 immune response-dependent immunity, inﬂammation,
and tissue repair in several important immune-mediated disorders.
In the current study, we sought to determine whether IL-33 is an
important regulator in renal ischaemic/reperfusion injury (IRI).
Methods: Bilateral renal ischemia was imposed in C57BL/6 mice
under isoﬂuorane anesthesia. IL-33 was given by 5 consecutive
daily injections starting at day 5 before IRI operation. Adoptive
transfer of type 2 innate lymphoid cells into mice with IRI was used
to assess their in vivo functions.
Results: Treating IRI mice with IL-33 signiﬁcantly improved renal
function and reduced renal injury. The possible mechanisms un-
derlying the protective effect of IL-33 were examined. Firstly, IL-33
increased the levels of IL-4, IL-5 and IL-13 in serum and kidney and
promoted induction of alternatively activated (M2) macrophages in
kidney. Moreover, the number of NK cells and neutrophils was
signiﬁcantly reduced in IRI mice treated with IL-33. A novel
ﬁnding of this study was that IL-33 increased the frequency of type
2 innate lymphoid cells (ILC2) and regulatory T cells (Tregs) in
kidney. However, adoptive transfer of ILC2 not only reduced renal
functional and histological injury in IRI mice but also induced M2
macrophages in kidney.
Conclusions: In conclusion, our data identify a mechanism
whereby IL-33 eliciting ILC2 and Tregs regulate macrophage
phenotype in kidney and prevent renal IRI.
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Introduction:We have recently characterized Foxp3+ regulatory T
cells, co-expressing the Th17 characteristic transcription factor
ROR t, as an independent and bi-functional T cell lineage (biTregs).
biTregs secrete both, anti-inﬂammatory (IL-10, IL-35), but also pro-
inﬂammatory (IL-17) cytokines. Studies in a model of acute cres-
centic glomerulonephritis have suggested that pro- inﬂammatory
biTreg functions are largely mediated by ROR t. This is of high
clinical relevance, since multiple ROR t blocking agents areS11
